Novo Nordisk's Wegovy pill was prescribed 18,410 times in the U.S. in the first full week after its launch in an encouraging ...

Novo Nordisk's Wegovy pill tracked 18,410 U.S. prescriptions in the first full week after its launch, IQVIA data shared by ...

Eli Lilly ( LLY +0.87%) delivered a gain worthy of a technology growth stock last year. The pharma giant's shares soared 39%, ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.

Prescriptions of the pill version of its blockbuster weight-loss drug, Wegovy, have surged. The oral weight-loss drug introduced by Novo Nordisk this year in the U.S. is quickly being adopted.

The City of Providence, along other municipalities and states, is taking big pharma to court over the price of insulin.

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

Many patients using GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, an analysis of ...

Diabetes care is undergoing a major transformation driven by GLP-1 receptor agonists, which have expanded beyond glycemic ...

We look at the Novo Nordisk A/S outlook for 2026: new CEO focus, oral Wegovy edge vs Eli Lilly, and double-digit growth ...

Novo Nordisk oral Wegovy records 3,071 prescriptions in four days. Shares jump 6.5% as Eli Lilly oral weight loss drug awaits ...

Despite ushering in the current GLP-1 era, Novo Nordisk has fallen behind its chief rival Eli Lilly, which has exceeded the Danish pharma in terms of sales.